Intelligent Bio Solutions Inc Revenue Growth Rates (INBS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Intelligent Bio Solutions Inc   (NASDAQ: INBS)
 

INBS's Revenue Growth by Quarter and Year

Intelligent Bio Solutions Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/INBS/growth
https://api.csimarket.com/api/v1/companies/INBS/fundamentals
https://api.csimarket.com/api/v1/companies/INBS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
INBS Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September 1.39
FY 1.39

INBSs Annual Revenue
Intelligent Bio Solutions Inc 's Revenue in the fiscal year 2026 $ 4.22 millions
Intelligent Bio Solutions Inc 's Revenue in the fiscal year 2025 $ 2.25 millions
Intelligent Bio Solutions Inc 's Revenue in the fiscal year 2024 $ 2.43 millions
Intelligent Bio Solutions Inc 's Revenue in the fiscal year 2023 $ 1.26 millions
Intelligent Bio Solutions Inc 's Revenue in the fiscal year 2022 $ 0.44 millions




INBS Revenue first quarter 2026 Y/Y Growth Comment
Intelligent Bio Solutions Inc reported Revenue improvement of 25.39% year on year in the first quarter 2026, to $ 1.39 millions, this is lower than Intelligent Bio Solutions Inc 's recent average Revenue surge of 130.42%.

Looking into first quarter 2026 results within Medical Equipment & Supplies industry 36 other companies have achieved higher Revenue growth. While Intelligent Bio Solutions Inc ' s Revenue rise of 25.39% ranks overall at the positon no. 626 in the first quarter 2026.


INBS Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September 25.39 %
FY   -

Financial Statements
Intelligent Bio Solutions Inc 's first quarter 2026 Revenue $ 1.39 millions INBS's Income Statement
Intelligent Bio Solutions Inc 's first quarter 2025 Revenue $ 1.11 millions Quarterly INBS's Income Statement


INBS Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March -
2nd Quarter December -
1st Quarter September 21.03 %
FY (Year on Year)   -


Back to INBS Growth rate Comparisons >> Back to INBS Growth rate Comparisons >>


Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #37
Healthcare Sector #147
Overall #626

Revenue Y/Y Growth Statistics
High Average Low
1092.68 % 130.42 % -100 %
(Sep 30 2023)   (Mar 31 2025)
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #37
Healthcare Sector #147
Overall #626
Revenue Y/Y Growth Statistics
High Average Low
1092.68 % 130.42 % -100 %
(Sep 30 2023)   (Mar 31 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Intelligent Bio Solutions Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
2809.63 % 280.38 % -100 %
(Sep 30 2025)  


INBS's I. Quarter Q/Q Revenue Comment
Intelligent Bio Solutions Inc achieved in the I. Quarter 2026 below company average Revenue jump of 21.03% quarter on quarter, to $ 1.39 millions.

Within Medical Equipment & Supplies industry 33 other companies have achieved higher Revenue quarter on quarter growth. While Intelligent Bio Solutions Inc 's Revenue growth quarter on quarter, overall rank is 879.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #137
Overall #879
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #137
Overall #879
Revenue Q/Q Growth Statistics
High Average Low
2809.63 % 280.38 % -100 %
(Sep 30 2025)  


INBS's I. Quarter Q/Q Revenue Comment
Intelligent Bio Solutions Inc achieved in the I. Quarter 2026 below company average Revenue jump of 21.03% quarter on quarter, to $ 1.39 millions.

Within Medical Equipment & Supplies industry 33 other companies have achieved higher Revenue quarter on quarter growth. While Intelligent Bio Solutions Inc 's Revenue growth quarter on quarter, overall rank is 879.


Intelligent Bio Solutions Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 4.50
Y / Y Revenue Growth (TTM) 36.55 %
Year on Year Revenue Growth Overall Ranking # 2941
Seqeuential Revenue Change (TTM) 6.64 %
Seq. Revenue Growth (TTM) Overall Ranking # 2479


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, Intelligent Bio Solutions Inc 's cumulative twelve months Revenue were $ 5 millions, company would post below average annual Revenue growth of 6.64% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the Intelligent Bio Solutions Inc 's Revenue growth from the 1.15% growth in Jun 30 2026.

In the Healthcare sector 405 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2631 to 2941.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 132
Healthcare Sector # 406
Overall # 2941

Revenue TTM Y/Y Growth Statistics
High Average Low
132.7 %
 53.9 %
-10.55 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 132
Sector # 360
S&P 500 # 2479
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, Intelligent Bio Solutions Inc 's cumulative twelve months Revenue were $ 5 millions, company would post below average annual Revenue growth of -10.55% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the Intelligent Bio Solutions Inc 's Revenue growth from the 1.15% growth in Jun 30 2026.

In the Healthcare sector 405 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2631 to 2941.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 132
Healthcare Sector # 406
Overall # 2941

Revenue TTM Y/Y Growth Statistics
High Average Low
132.7 %
53.9 %
-10.55 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 132
Sector # 360
S&P 500 # 2479




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
INBS's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Xeris Biopharma Holdings Inc 44.16%$ 44.158 millions
Nephros Inc 43.60%$ 43.602 millions
Cardiff Oncology Inc 42.50%$ 42.500 millions
Neurocrine Biosciences Inc 41.24%$ 41.238 millions
Transmedics Group Inc 41.15%$ 41.149 millions
Uniqure N v 40.39%$ 40.394 millions
Harrow Inc 40.00%$ 40.001 millions
Mirum Pharmaceuticals Inc 39.63%$ 39.629 millions
Caredx Inc 39.29%$ 39.285 millions
Halozyme Therapeutics Inc 39.15%$ 39.154 millions
Eli Lilly And Company38.61%$ 38.613 millions
Sbc Medical Group Holdings Incorporated37.48%$ 37.478 millions
Myomo Inc 37.42%$ 37.416 millions
Editas Medicine Inc 37.41%$ 37.412 millions
Beyond Air Inc 36.55%$ 36.545 millions
Clearpoint Neuro Inc 36.27%$ 36.271 millions
Regeneron Pharmaceuticals Inc 36.27%$ 36.265 millions
Travere Therapeutics Inc 36.22%$ 36.215 millions
Omada Health Inc 36.13%$ 36.133 millions
Guardant Health Inc 36.12%$ 36.116 millions
Natera Inc 34.08%$ 34.077 millions
Establishment Labs Holdings Inc 34.08%$ 34.075 millions
Beone Medicines Ltd 33.86%$ 33.861 millions
Ceribell Inc 33.72%$ 33.721 millions
Zomedica Corp 33.12%$ 33.123 millions
Intuitive Surgical Inc 32.71%$ 32.714 millions
Adc Therapeutics Sa32.20%$ 32.197 millions
Biomarin Pharmaceutical Inc32.02%$ 32.019 millions
The Pennant Group Inc 31.96%$ 31.965 millions
Beta Bionics Inc 30.92%$ 30.923 millions


About Intelligent Bio Solutions Inc Revenue Growth Rates (INBS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Intelligent Bio Solutions Inc (CIK 1725430).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-26-050881
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Intelligent Bio Solutions Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.